Product
PCLX-001
1 clinical trial
2 indications
Indication
B-cell Non-Hodgkin LymphomaIndication
Advanced Solid TumorClinical trial
Phase I Trial of PCLX-001 in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma and Advanced Solid MalignanciesStatus: Recruiting, Estimated PCD: 2024-10-28